Bridging Trial to Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain 3D7 Within the WRAIR Controlled Human Malaria Infection (CHMI) Model
Condition:   Malaria,Falciparum Intervention:   Biological: Plasmodium falciparum malaria parasite Sponsor:   U.S. Army Medical Research and Materiel Command Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2019 Category: Research Source Type: clinical trials